期刊文献+

细胞密度和感染复数对SARS病毒在Vero细胞中增殖的影响 被引量:10

Optimal Cell Density and Multiplicity of Infection for the Propagation of SARS-CoV in Vero Cells
下载PDF
导出
摘要 阐明宿主细胞密度和病毒感染复数(MOI)对SARS冠状病毒增殖的影响,为SARS灭活疫苗的研究奠定基础。采用析因设计方法,考虑MOI(0.01、0.05和0.1)与细胞密度(2×104、4×104和8×104/cm2)2个3水平实验因素,在各水平组合条件下培养SARS病毒,以组织培养半数感染量(TCID50)作为观测指标,分析SARS冠状病毒滴度在不同增殖条件下的差异。结果表明,MOI、宿主细胞密度和二者之间的交互作用对SARS病毒滴度的影响分别具有非常显著性差异(F=12.70,P<0.01)、显著性差异(F=6.94,P<0.05)和非常显著性差异(F=8.22,P<0.01)。在0.01MOI和8×104/cm2条件下,病毒滴度达5.57×105TCID50/mL。说明SARS冠状病毒在培养细胞中的增殖能力显著依赖于宿主细胞密度、病毒感染复数和二者的交互作用。 To clarify the effects of cell density at infection and multiplicity of infection (MOI) on SARS coronavirus propagation in Vero cell cultures and lay a foundation for SARS-CoV vaccine development. The factorial design methods and analysis of variance were adopted to compare SARS-CoV titers (TCID50) after infection at MOIs of 0.01, 0.05 and 0.1 with different cell density of 2×104, 4×104 and 8×104 cell/cm2. There was great significant difference in the mean TCID50 among MOI of 0.01, 0.05 and 0.1(F=12.70, P<0.01). There was significant difference in the mean TCID50 among 2×104, 4×104 and 8×104 cells/cm2 (F=6.94, P<0.05). There was great significant difference in the mean TCID50 in reciprocal condition(F=8.22, P<0.01). The optimal SARS-CoV titer (5.57×105 TCID50/mL) was obtained with cultures seeded at about 8×104 cells /cm2 and at an MOI of 0.01. These results suggested that SARS coronavirus propagation dependent upon cell density, MOI and their reciprocity at infection.
出处 《生物技术通讯》 CAS 2005年第3期274-275,共2页 Letters in Biotechnology
  • 相关文献

参考文献6

二级参考文献7

  • 1[1]Gaertner DJ, Winograd DF, Compton SR et al. Development and optimization of plaque assays for rat coronaviruses.J Virol Methods, 1993,43(1):53
  • 2[2]Kapil S, Chard-Bergstrom C, Bolin P et al. Plaque variations in clinical isolates of bovine coronavirus. J Vet Diagn Invest,1995 ,7(4):538
  • 3[3]Mochizuki M, Mitsutake Y, Miyanohara Y et al. Antigenic and plaque variations of serotype II feline infectious peritonitis coronaviruses. J Vet Med Sci,1997,59(4):253
  • 4Yang K D,Acta Virol,1995年,39卷,19页
  • 5江丽芳,中山医科大学学报,1993年,14卷,288页
  • 6孙余华,国外医学免疫学分册,1992年,15卷,1期,16页
  • 7QIN E'de,ZHU Qingyu,YU Man, FAN Baochang,CHANG Guohui,SI Bingyin,YANG Bao,PENG Wenming,JIANG Tao,LIU Bohua,DENG Yongqiang,LIU Hong,ZHANG Yu,WANG Cui,LI Yuquan,GAN Yonghua,LI Xiaoyu,L Fushuang,TAN Gang,CAO Wuchun,YANG Ruifu,WANG Jian,LI Wei,XU Zuyuan,LI Yan,WU Qingfa,LIN Wei,CHEN Weijun,TANG Lin,DENG Yajun,HAN Yujun,LI Changfeng,LEI Meng,LI Guoqing,LI Wenjie,L Hong,SHI Jianping,TONG Zongzhong,ZHANG Feng,LI Songgang,LIU Bin,LIU Siqi,DONG Wei,WANG Jun,Gane K-S Wong,YU Jun,YANG Huanming.A complete sequence and comparative analysis of a SARS-associated virus(Isolate BJ01)[J].Chinese Science Bulletin,2003,48(10):941-948. 被引量:122

共引文献17

同被引文献68

引证文献10

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部